Tata Medical Center (TMC) in Kolkata, India, a project designed by CannonDesign, has become an instrumental comprehensive cancer care institution for the region. Recently, it also became authorized by the Indian Council of Medical Research to conduct COVID-19 tests and treat cancer patients infected by the virus.
There are six private testing facilities in the state of West Bengal, including TMC Kolkata. As countries around the world seek to bolster their testing capacity, the more sites the better, particularly for India, the world’s second most populous country.
The CannonDesign team from our Mumbai office spoke with hospital representatives about how the hospital has adapted to treat both COVID and non-COVID cancer patients. Representatives share that the hospital identified a zone on the second floor of Phase II of the facility, which houses acute and critical care spaces with negative isolation rooms, to treat COVID-positive cancer patients and staff members. The original intent of Phase II was to increase bed capacity. Almost immediately after Tata Medical Center opened its first phase in 2011, the demand for its services far outweighed the capacity of its 183 inpatient bed hospital and outpatient facility.
The hospital also shared that it has seen a drop in outpatient traffic since the nationwide lockdown started on March 24. While Tata Medical Center is actively encouraging its patients across India to opt for the hospital’s online consultation service, the hospital remains fully operational, continuing to offer its services to patients and families in dire need.